SEC Form D · filed October 14, 2022
INVIVO THERAPEUTICS HOLDINGS CORP
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Richard Toselli · Cambridge, MAExec · DirectorRichard Christopher · Cambridge, MAExecDaniel A. Marshak · Cambridge, MADirectorC. A. Merrifield · Cambridge, MADirectorRichard A. Roberts · Cambridge, MADirectorChristina A. Morrison · Cambridge, MADirectorRobert A. Rosenthal · Cambridge, MADirectorTerry D. Borst · Atascadero, CADirectorClaudio D. Ruben · Santa Fe, NMDirectorJuan M. Hill · Waltham, MAExecBrandon T. Brahm · New York, NYExec · DirectorSteven T. Berg · Waltham, MADirectorMatthew B. Ruesch · McLean, VADirectorJoshua T. Weisenbeck · New York, NYDirectorHeather A. Hamel · Cambridge, MAExecSarah Tavel · New York, NYDirectorMichael Vela · Chesterfield, MODirectorJeff Smith · Chesterfield, MOExecPortage Ventures III GP Inc · Toronto, Ontario, CanadaDirectorStalin Ramirez · Fair Lawn, NJExec · DirectorShaheed Bailey · Clifton, NJDirectorCary G. Marr · George Town, Grand Cayman, Cayman IslandsDirectorHeather A. Hamel · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗